ACAD SG&A Expense Growth
Acadia Pharmaceuticals Inc · SG&A Expense Growth
ACAD SG&A Expense Growth
Latest reported12.38%period ending
ACAD FY SG&A Growth (YoY) (0.00% → 12.38%)
Latest values, visible window
High-resolution chart · PNG
ACAD sg&a expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 12.3797% | |
| 21.3588% | |
| 9.0428% | |
| -6.802% | |
| 1.8955% | |
| 19.3537% | |
| 22.5318% | |
| 4.1935% | |
| 36.7947% | |
| 105.339% | |
| 177.2811% | |
| 157.4528% | |
| 81.7402% | |
| -8.0289% | |
| 17.7654% | |
| -37.1523% | |
| -12.9971% | |
| -3.6602% | |
| 8.0888% | |
| -28.6881% | |
| 119.645% | |
| 73.1988% | |
| 5.0894% | |
| 5.9851% | |
| 25.2417% | |
| 0% |